SHP 637Alternative Names: SHP637
Latest Information Update: 01 Feb 2016
At a glance
- Originator Shire
- Class Gene therapies; RNA
- Mechanism of Action Gene transference
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Inborn urea cycle disorders
Most Recent Events
- 01 Feb 2016 Preclinical trials in Inborn urea cycle disorders in Ireland (unspecified route) before February 2016